Evotec SE (EVO) EBT (QoQ) (2009 - 2025)
Evotec SE (EVO) EBT (QoQ) (2009 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Evotec SE | 689.00 Mn | 688.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -200,734.07% |
| Dec 31, 2024 | -402,193.87% |
| Dec 31, 2023 | -266,180.07% |
| Sep 30, 2023 | 246.34% |
| Dec 31, 2022 | -359,668.44% |
| Sep 30, 2022 | 268.37% |
| Jun 30, 2022 | 66.34% |
| Mar 31, 2022 | -100.03% |
| Dec 31, 2021 | 163,468.84% |
| Sep 30, 2021 | 129.19% |
| Jun 30, 2021 | 10.01% |
| Mar 31, 2021 | -99.79% |
| Dec 31, 2020 | 350,283.94% |
| Sep 30, 2010 | -53.39% |
| Jun 30, 2010 | 126,808.46% |
| Mar 31, 2010 | 100.00% |
| Jun 30, 2009 | -41,099.56% |